Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 5
2005 2
2006 2
2007 5
2008 9
2009 9
2010 11
2011 7
2012 7
2013 13
2014 13
2015 13
2016 11
2017 20
2018 11
2019 15
2020 22
2021 28
2022 16
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Cancer Cachexia: Its Mechanism and Clinical Significance.
Nishikawa H, Goto M, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Nishikawa H, et al. Among authors: asai a. Int J Mol Sci. 2021 Aug 6;22(16):8491. doi: 10.3390/ijms22168491. Int J Mol Sci. 2021. PMID: 34445197 Free PMC article. Review.
Metabolic Syndrome and Sarcopenia.
Nishikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K. Nishikawa H, et al. Among authors: asai a. Nutrients. 2021 Oct 7;13(10):3519. doi: 10.3390/nu13103519. Nutrients. 2021. PMID: 34684520 Free PMC article. Review.
Screening Tools for Sarcopenia.
Nishikawa H, Asai A, Fukunishi S, Takeuchi T, Goto M, Ogura T, Nakamura S, Kakimoto K, Miyazaki T, Nishiguchi S, Higuchi K. Nishikawa H, et al. Among authors: asai a. In Vivo. 2021 Nov-Dec;35(6):3001-3009. doi: 10.21873/invivo.12595. In Vivo. 2021. PMID: 34697131 Free PMC article. Review.
Pathophysiology and mechanisms of primary sarcopenia (Review).
Nishikawa H, Fukunishi S, Asai A, Yokohama K, Nishiguchi S, Higuchi K. Nishikawa H, et al. Among authors: asai a. Int J Mol Med. 2021 Aug;48(2):156. doi: 10.3892/ijmm.2021.4989. Epub 2021 Jun 29. Int J Mol Med. 2021. PMID: 34184088 Review.
Hepatic Inflammatory Pseudotumor-Focusing on Its Heterogeneity.
Kim SR, Kim SK, Koma YI, Sasaki M, Asai A, Nishikawa H. Kim SR, et al. Among authors: asai a. Diagnostics (Basel). 2023 Sep 4;13(17):2857. doi: 10.3390/diagnostics13172857. Diagnostics (Basel). 2023. PMID: 37685395 Free PMC article. Review.
Dysbiosis and liver diseases (Review).
Nishikawa H, Fukunishi S, Asai A, Yokohama K, Ohama H, Nishiguchi S, Higuchi K. Nishikawa H, et al. Among authors: asai a. Int J Mol Med. 2021 Sep;48(3):183. doi: 10.3892/ijmm.2021.5016. Epub 2021 Jul 30. Int J Mol Med. 2021. PMID: 34328191 Review.
Sarcopenia and Frailty in Liver Cirrhosis.
Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Nishikawa H, et al. Among authors: asai a. Life (Basel). 2021 Apr 27;11(5):399. doi: 10.3390/life11050399. Life (Basel). 2021. PMID: 33925660 Free PMC article. Review.
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study.
Wong YJ, Tran S, Huang CF, Hsu YC, Preda C, Toyoda H, Liu J, Jun DW, Landis C, Huang DQ, Gila A, Negoita L, Yasuda S, Tseng CH, Tsai PC, Uojima H, Nozaki A, Chuma M, Atsukawa M, Ishigami M, Itokawa N, Iio E, Lam CP, Watanabe T, Asai A, Yokohama K, Abe H, Enomoto M, Kawada N, Tamori A, Lee DH, Jun MJ, Do S, Vo DKH, Liu L, Li J, Ji F, Wang W, Li Y, Wang X, Guo F, Xu Q, Jing L, Ye Q, Pan H, Zhang J, Wen X, Wang Q, Ren H, Cai D, Shang J, Liu J, Lu C, Zang W, Li J, Niu J, Zhang M, Wu C, Huang R, Maeda M, Nakanishi A, Yeh ML, Chuang WL, Huang JF, Dai C, Ishikawa T, Takaguchi K, Senoh T, Trinh HN, Takahashi H, Eguchi Y, Quek SXZ, Haga H, Ogawa E, Wong G, Buti M, Fukunishi S, Ueno Y, Yuen MF, Tanaka Y, Lim SG, Cheung R, Yu ML, Nguyen MH. Wong YJ, et al. Among authors: asai a. Hepatol Int. 2023 Oct;17(5):1150-1161. doi: 10.1007/s12072-023-10547-4. Epub 2023 Jun 5. Hepatol Int. 2023. PMID: 37273170
Body Composition in Chronic Liver Disease.
Nishikawa H, Kim SK, Asai A. Nishikawa H, et al. Among authors: asai a. Int J Mol Sci. 2024 Jan 12;25(2):964. doi: 10.3390/ijms25020964. Int J Mol Sci. 2024. PMID: 38256036 Free PMC article. Review.
Sarcopenia, frailty and type 2 diabetes mellitus (Review).
Nishikawa H, Fukunishi S, Asai A, Yokohama K, Ohama H, Nishiguchi S, Higuchi K. Nishikawa H, et al. Among authors: asai a. Mol Med Rep. 2021 Dec;24(6):854. doi: 10.3892/mmr.2021.12494. Epub 2021 Oct 15. Mol Med Rep. 2021. PMID: 34651658 Review.
212 results